CreatorsPublishersAdvertisers
View more in
Health

What to Know About Guillain-Barré Syndrome

thecut.com
 2021-07-15

Cover picture for the articleThis week, the FDA announced that it would attach a warning to the Johnson & Johnson COVID-19 vaccine pertaining to its very slightly elevated risk association with Guillain-Barré syndrome, a rare neurological disorder. The announcement came after approximately 100 suspected cases were identified among the more than 12 million people who’ve received the Johnson & Johnson vaccine thus far. In April, distribution of the J&J vaccine was briefly “paused” due to concerns about a rare blood-clotting disorder; the shot was reinstated after a safety review concluded the side effect was extremely rare. As the FDA reaffirmed that “the known and potential benefits clearly outweigh the known and potential risks,” there is no reason to believe the Johnson & Johnson vaccine will be paused again.

www.thecut.com

Comments / 0

Comments / 0